Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

LON/0RC6 stock hub

LON/0RC6 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0RC6is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.5B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0RC6

In the news

Latest news · LON/0RC6

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E22.6

P25 12.9P50 16.9P75 23.5

Trailing P/E21.2

P25 15.9P50 22.9P75 35.8

ROE36

P25 -54.2P50 2.1P75 13.7

ROIC48.9

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0RC6 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

210

Groups with data

Currency

EUR

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Spain
Country code	UK
Employees	505
Employees Change	-9%
Employees Change Percent	-1.77
Enterprise value	EUR 1.4B
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	ES0169501022
Last refreshed	2026-05-10
Market cap	EUR 1.5B
Price	EUR 99.73
Price currency	EUR
Rev Per Employee	389,783.76x
Sector	Healthcare
Sic	2836
Symbol	lon/0RC6
Website	https://www.pharmamar.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.71%
EV Earnings	19.76x
EV/EBIT	24.95x
EV/EBITDA	22.26x
EV/FCF	26.19x
EV/Sales	7.13x
FCF yield	3.55%
Forward P/E	22.61x
P/B ratio	6.84x
P/E ratio	21.24x
P/S ratio	7.58x
PE Ratio3 Y	237.2x
PE Ratio5 Y	144.96x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	28.58%
EBITDA Margin	31.17%
FCF margin	26.92%
Gross margin	94.45%
Gross Profit	EUR 185.9M
Gross Profit Growth	28.32%
Gross Profit Growth Q	10.67%
Gross Profit Growth3 Y	8.84%
Gross Profit Growth5 Y	0.84%
Net Income	EUR 70.3M
Net Income Growth	304.85%
Net Income Growth3 Y	40.86%
Net Income Growth5 Y	-2.4%
Pretax Margin	28.9%
Profit Margin	35.7%
Profit Per Employee	EUR 139,134
ROA	11.2
Roa5y	6.83
ROCE	21.76
ROE	35.99
Roe5y	27.39
ROIC	48.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	12.33%
Cagr1y	37.04%
Cagr3y	40.79%
Cagr5y	4.26%
Div CAGR3	15.29%
FCF Growth5 Y	-11.64%
OCF Growth5 Y	-10.28%
Revenue Growth	28.27x
Revenue Growth Q	10.4x
Revenue Growth3 Y	8.37x
Revenue Growth5 Y	0.33x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.63
Assets	EUR 336.4M
Cash	EUR 146.6M
Current Assets	EUR 236.5M
Current Liabilities	EUR 77.2M
Debt	EUR 41.5M
Debt EBITDA	EUR 0.66
Debt Equity	EUR 0.19
Debt FCF	EUR 0.78
Equity	EUR 218M
Interest Coverage	39.28
Liabilities	EUR 118.4M
Long Term Assets	EUR 99.9M
Long Term Liabilities	EUR 41.2M
Net Cash	EUR 105.1M
Net Cash By Market Cap	EUR 7.04
Net Cash Growth	35.33%
Net Debt EBITDA	EUR -1.71
Net Debt Equity	EUR -0.48
Net Debt FCF	EUR -1.98
Tangible Book Value	EUR 214.7M
Tangible Book Value Per Share	EUR 12.37
WACC	5.93

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.06
Inventory Turnover	0.24
Net Working Capital	EUR 25.7M
Quick ratio	2.33
Working Capital	EUR 160.9M
Working Capital Turnover	EUR 1.16

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	24.36%
Dividend Growth Years	6%
Dividend per share	EUR 0.68
Dividend Years	6
Dividend Yield	0.67%
Ex Div Date	2025-06-25
Last Dividend	EUR 0.68
Payout Frequency	Annual
Payout Ratio	17.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	219.72%
1Y total return	37.01%
200-day SMA	82.3
3Y total return	179.12%
50-day SMA	89.86
50-day SMA vs 200-day SMA	50over200
5Y total return	23.17%
All Time High	147.9
All Time High Change	-32.57%
All Time High Date	2020-10-16
All Time Low	10.73
All Time Low Change	829.06%
All Time Low Date	2018-10-26
ATR	3.7
Beta	0.32
Ch YTD	34.43
High	105.2
High52	105.4
High52 Date	2026-05-07
High52ch	-5.38%
Low	98.55
Low52	70.2
Low52 Date	2025-11-07
Low52ch	42.06%
Ma50ch	10.98%
Price vs 200-day SMA	21.18%
RSI	57.02
RSI Monthly	65.47
RSI Weekly	72.37
Sharpe ratio	0.87x
Sortino ratio	1.43
Total Return	0.67%
Tr YTD	34.43
Tr1m	17.74%
Tr1w	4.51%
Tr3m	30.55%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 56.3M
Operating Income Growth	738.6
Operating Income Growth3 Y	46.51
Operating Income Growth5 Y	-9.08
Operating margin	28.58

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,425,751%
Net Borrowing	-6,279,265
Shares Insiders	12.04%
Shares Institutions	10.43%
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 53M
Average Volume	12,401.9x
Bv Per Share	12.56
CAPEX	EUR -6.4M
Ch10y	201.2
Ch1m	17.74
Ch1w	4.51
Ch1y	35.66
Ch3m	30.55
Ch3y	167.4
Ch5y	17.1
Ch6m	40.78
Change	-3.04%
Change From Open	-3.18
Close	102.9
Days Gap	0.15
Depreciation Amortization	5,062,165.4
Dollar Volume	261,578.7
Earnings Date	2026-04-29
EBIT	EUR 56.3M
EBITDA	EUR 61.4M
EPS	EUR 4.05
F Score	7
FCF	EUR 53M
FCF EV Yield	3.82x
Financing CF	-32,076,097
Fiscal Year End	December
Founded	1,986
Graham Number	39.23766
Graham Upside	-60.65
Income Tax	EUR -13.4M
Investing CF	-37,623,380
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Last Split Date	2020-07-22
Last Split Type	Reverse
Lynch Fair Value	EUR 23.48
Lynch Upside	-76.45
Ma150	81.53
Ma150ch	22.31%
Ma20	97.47
Ma20ch	2.31%
Net CF	-9,977,775
Next Earnings Date	2026-07-27
Open	103
P FCF Ratio	28.16
P OCF Ratio	25.13
Payment Date	2025-06-27
Position In Range	17.67
Ppne	51,605,195.4
Price Date	2026-05-08
Price EBITDA	EUR 24.32
Ptbv Ratio	6.95
Relative Volume	0.21x
Revenue	196,840,797x
Tax By Revenue	-6.79x
Tr6m	40.78%
Volume	2,623
Z Score	8.74

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0RC6 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.7%

$0.68 annual per share

Payout ratio

+17.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

6 consecutive years of growth

Total shareholder yield

+0.7%

Next ex-dividend date: 2025-06-25

Performance

LON/0RC6 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0RC6?

Insider, institutional, and short-interest positioning.

Institutional ownership

+10.4%

Share of float held by funds and institutions

Insider ownership

+12.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

LON/0RC6 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.0

Neutral momentum band

Price vs 200-day MA

+21.2%

50/200-day relationship not available

Beta (5Y)

0.32

Less volatile than the market

Sharpe ratio

0.87

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0RC6

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0RC6 stock rating?

lon/0RC6 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0RC6 analysis?

The full report lives at /stocks/lon/0RC6/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0RC6?

The latest report frames lon/0RC6 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0RC6 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.